Cognition Therapeutics Inc. Made Headway
Wed, Nov 30, 2022 at 07:04 PM
Cognition Therapeutics Inc. (CGTX:NASDAQ) soared at $3.51, a gain of 41.5%. On Wed, Nov 30, 2022, CGTX:NASDAQ hit a New 2-Week High of $3.51. The stock got featured on our News Catalysts scanner on Mon, Nov 28, 2022 at 08:08 AM in the 'BIOTECH' category. From Wed, Nov 16, 2022, the stock recorded 77.78% Up Days and 60.00% Green Days
The stock spiked on Thu, Aug 04, 2022 at $6.27 with a volume of 21M+.
About Cognition Therapeutics Inc. (CGTX:NASDAQ)
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative...
Top 10 Gainers:
- Biophytis SA (BPTS:NASDAQ), 92.03%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 60.08%
- SatixFy Communications Ltd. (SATX:NYSEMKT), 48.6%
- XPeng Inc. American depositary shares each representing two Class A (XPEV:NYSE), 47.28%
- Biodesix Inc. (BDSX:NASDAQ), 47.06%
- Top Ships Inc. (TOPS:NASDAQ), 45.19%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 44.54%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 41.53%
- Vapotherm, Inc. (VAPO:NYSE), 34.79%
- Myomo, Inc. (MYO:NYSEMKT), 33.4%